Stockscreener 앱 받기
1.48
8.82%
0.12
시간 외 거래:
1.48
전일 마감가:
$1.36
열려 있는:
$1.41
하루 거래량:
545.07K
Relative Volume:
0.78
시가총액:
$54.81M
수익:
-
순이익/손실:
$-25.94M
주가수익비율:
-1.0725
EPS:
-1.38
순현금흐름:
$-15.79M
1주 성능:
+28.70%
1개월 성능:
+49.65%
6개월 성능:
-14.94%
1년 성능:
-25.63%
1일 변동 폭
$1.35
$1.48
1주일 범위
$1.13
$1.48
52주 변동 폭
$0.87
$2.74
MAIA Biotechnology Inc Stock (MAIA) Company Profile
명칭
MAIA Biotechnology Inc
전화
312 416 8592
주소
444 West Lake Street, Suite 1700, Chicago
MAIA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MAIA
MAIA Biotechnology Inc
|
1.48 | 50.36M | 0 | -25.94M | -15.79M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.99 | 116.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.71 | 82.52B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.69 | 52.67B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
849.95 | 52.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.42 | 37.70B | 447.02M | -1.18B | -906.14M | -6.1812 |
MAIA Biotechnology Inc 주식(MAIA)의 최신 뉴스
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings - The Manila Times
Chaouki Steven M buys MAIA Biotechnology shares worth $49999 By Investing.com - Investing.com Australia
Stan Smith buys MAIA Biotechnology shares worth $69,999 By Investing.com - Investing.com Australia
Stan Smith buys MAIA Biotechnology shares worth $69,999 - Investing.com
Chaouki Steven M buys MAIA Biotechnology shares worth $49999 - Investing.com
Louie Ngar Yee buys MAIA Biotechnology (MAIA) shares worth $99999 - Investing.com
Swing Trade: Why hedge funds are buying MAIA Biotechnology Inc stockJuly 2025 Movers & Safe Entry Momentum Stock Tips - moha.gov.vn
Can MAIA Biotechnology Inc. stock double in next 5 yearsPortfolio Gains Report & Capital Efficiency Focused Ideas - DonanımHaber
How MAIA Biotechnology Inc. stock compares to industry benchmarksWeekly Profit Summary & AI Forecasted Entry/Exit Points - Улправда
Can MAIA Biotechnology Inc. stock maintain operating marginsJuly 2025 Intraday Action & Expert Approved Momentum Ideas - Bölüm Sonu Canavarı
Why MAIA Biotechnology Inc. stock is upgraded to buy2025 Valuation Update & Daily Growth Stock Tips - DonanımHaber
MAIA Biotechnology announces $2.25M private placement deal - MSN
MAIA Biotechnology Announces $2.25M Private Placement Deal - TipRanks
MAIA Biotechnology (NYSE American: MAIA) details $2.25M private placement - Stock Titan
MAIA Biotechnology Announces $1.51 Million Private Placement - The Manila Times
MAIA Biotechnology, Inc. announced that it expects to receive $1.289791 million in funding - marketscreener.com
MAIA Biotechnology Earnings Notes - Trefis
MAIA Biotechnology Announces Significant Insider Buying - TipRanks
MAIA Biotechnology, Inc. Announces Key Developments in Cancer Therapy - TradingView — Track All Markets
MAIA Biotechnology (NYSE: MAIA) starts Ateganosine Phase 3 trial and notes insider buying - Stock Titan
MAIA Biotechnology (NYSE American: MAIA) begins Phase 3 NSCLC study of telomere-targeting ateganosine - Stock Titan
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer - Yahoo Finance
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential - Yahoo Finance
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach - The Manila Times
MAIA Biotechnology Advances NSCLC Treatment with Ateganosine - TipRanks
MAIA Biotechnology, Inc. Targets $50B Immunotherapy Market with New Approach - TradingView — Track All Markets
MAIA Biotechnology (NYSE: MAIA) highlights $50B immunotherapy market in press release - Stock Titan
Prepare Yourself for Liftoff: MAIA Biotechnology Inc (MAIA) - setenews.com
Director Makes Bold Move with Major Stock Purchase in MAIA Biotechnology! - TipRanks
Dir Smith Buys 13,740 ($16.4K) Of Maia Biotechnology Inc [MAIA] - TradingView — Track All Markets
Can MAIA Biotechnology Inc. stock sustain revenue momentum2025 Price Targets & Real-Time Price Movement Reports - Newser
How MAIA Biotechnology Inc. stock reacts to bond yieldsWeekly Gains Summary & Free Technical Pattern Based Buy Signals - Newser
Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock By Investing.com - Investing.com Australia
Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock - Investing.com
Is MAIA Biotechnology Inc. stock among top earnings plays2025 Stock Rankings & Daily Chart Pattern Signals - Newser
How MAIA Biotechnology Inc. stock compares with top peersMarket Trend Summary & Fast Gain Swing Alerts - Newser
Vitoc Vlad, CEO of Maia Biotechnology, buys $10k in shares - Investing.com Canada
Why hedge funds are buying MAIA Biotechnology Inc. stockRisk Management & Daily Risk Controlled Trade Plans - Newser
MAIA Biotechnology Inc (MAIA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - setenews.com
How MAIA Biotechnology Inc. stock responds to policy changesTrade Analysis Report & Daily Risk Controlled Trade Plans - Newser
Will MAIA Biotechnology Inc. stock return to pre crash levels2025 Bull vs Bear & Smart Allocation Stock Reports - Newser
How MAIA Biotechnology Inc. stock compares with market leaders2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
Will MAIA Biotechnology Inc. stock recover faster than industryAnalyst Upgrade & Safe Entry Zone Tips - Newser
Why MAIA Biotechnology Inc. stock could rally stronglyJuly 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - Newser
Top Executives Make Bold Moves with Major Stock Purchases at MAIA Biotechnology! - TipRanks
MAIA SEC FilingsMAIA Biotechnology Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
MAIA Biotechnology Inc (MAIA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
MAIA Biotechnology Inc 주식 (MAIA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| CHAOUKI STEVEN M | Director |
Dec 22 '25 |
Buy |
1.22 |
40,849 |
49,999 |
151,873 |
| Louie Ngar Yee | Director |
Dec 22 '25 |
Buy |
1.22 |
81,699 |
100,000 |
1,248,888 |
| Smith Stan | Director |
Dec 05 '25 |
Buy |
1.20 |
13,740 |
16,441 |
4,580 |
| Vitoc Vlad | Chief Executive Officer |
Nov 28 '25 |
Buy |
1.14 |
50,000 |
56,830 |
881,421 |
| Vitoc Vlad | Chief Executive Officer |
Nov 26 '25 |
Buy |
1.05 |
22,000 |
23,019 |
853,421 |
| Luput Cristian | Director |
Nov 26 '25 |
Buy |
1.08 |
20,000 |
21,616 |
419,483 |
| Luput Cristian | Director |
Nov 28 '25 |
Buy |
1.11 |
18,145 |
20,230 |
437,628 |
| Smith Stan | Director |
Nov 26 '25 |
Buy |
1.04 |
15,000 |
15,582 |
1,364,289 |
| Luput Cristian | Director |
Nov 25 '25 |
Buy |
0.98 |
10,000 |
9,785 |
399,483 |
| Vitoc Vlad | Chief Executive Officer |
Nov 25 '25 |
Buy |
0.97 |
10,500 |
10,144 |
831,421 |
0.36%
0.21%
자본화:
|
볼륨(24시간):